TheraCell was awarded U.S. Patent Number 9,572,912, “Demineralized Bone Fibers having Controlled Geometry and Shapes and Methods Thereof,” its second U.S. patent for DBF™ technology.
TheraCell’s DBF is incorporated into AlloFuse® Cortical Fibers and AlloFuse® Fiber Boat demineralized cortical fiber allografts, commercialized by AlloSource and launched in 2016.
Sources: TheraCell, Inc.; ORTHOWORLD Inc.
TheraCell was awarded U.S. Patent Number 9,572,912, “Demineralized Bone Fibers having Controlled Geometry and Shapes and Methods Thereof,” its second U.S. patent for DBF™ technology.
TheraCell’s DBF is...
TheraCell was awarded U.S. Patent Number 9,572,912, “Demineralized Bone Fibers having Controlled Geometry and Shapes and Methods Thereof,” its second U.S. patent for DBF™ technology.
TheraCell’s DBF is incorporated into AlloFuse® Cortical Fibers and AlloFuse® Fiber Boat demineralized cortical fiber allografts, commercialized by AlloSource and launched in 2016.
Sources: TheraCell, Inc.; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
